Tilray Brands (TLRY) EPS (Basic) Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) EPS (Basic) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 97.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 97.39% |
| Feb 28, 2026 | 97.44% |
| Nov 30, 2025 | 60.00% |
| Aug 31, 2025 | 103.61% |
| May 31, 2025 | -8,189.35% |
| Feb 28, 2025 | -527.80% |
| Nov 30, 2024 | -56.00% |
| Aug 31, 2024 | 51.03% |
| May 31, 2024 | -95.63% |
| Feb 29, 2024 | 92.84% |
| Nov 30, 2023 | 54.55% |
| Aug 31, 2023 | 29.33% |
| May 31, 2023 | 137.18% |
| Feb 28, 2023 | -1,897.94% |
| Nov 30, 2022 | -1,204.02% |
| Aug 31, 2022 | -48.52% |
| May 31, 2022 | -177.45% |
| Feb 28, 2022 | -28.31% |
| Nov 30, 2021 | 103.44% |
| Aug 31, 2021 | 14.30% |